John Carter
Trustee 2003-2021 (deceased)
In his role his role as head of the Wellington Blood and Cancer Centre, John was an early ally in the Malaghan Institute’s first cancer immunotherapy trials in the late 1990s and remained a close friend and colleague, helping guide the institute in transforming its research into the clinic. In 2003 he joined the institute’s Trust Board and in 2021 was appointed Deputy Chair. He was recognised posthumously as a Distinguished Trustee in 2022.
An Associate Professor of the University of Otago, John clinically practiced as a haematologist with a focus on stem cell transplantation.
John was deeply knowledgeable about how to work within the New Zealand health and regulatory ecosystem and at the governance level, brought real people skills and the appropriate specialist perspective, guiding the institute’s science and clinical developments.
The changing face of allergy treatment
24 June 2026
Breakthrough Malaghan and University of Auckland cancer research advances into new biotech venture
16 June 2026
HRC funding to improve CAR T-cell ‘fitness’ and better fight cancer
11 June 2026
Our Changing World: Building New Zealand’s RNA capabilities
9 June 2026
Building the RNA Development Platform, one RNA at a time
27 May 2026
What's next for CAR T-cell therapy
27 May 2026